Cited by 54Muscle Physiology and DisordersGrowth Hormone and Insulin-like Growth FactorsHormonal and reproductive studies

Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle

Open access
Pöllänen, Eija, Ronkainen, Paula H.A., Horttanainen, Mia, Takala, Timo, Puolakka, Jukka, Suominen, Harri, Sipilä, Sarianna, Kovanen, Vuokko·2010·Growth Hormone & IGF Research

Abstract

Objectives To investigate the effects of combined hormone replacement therapy (HRT) and its effective agents on the IGF-1 signaling pathway.Design and methods To examine the effects of HRT on skeletal muscle in vivo, we utilized pre- and post-intervention samples from a randomized double blinded trial with 50-57-year-old women. The intervention included the year-long use of either HRT preparation (2 mg 17β-estradiol, E₂; 1mg norethisterone acetate, NETA, n=10) or placebo (CO, n=9). Microarray technology and quantitative PCR (qPCR) were used to study the expression of insulin-like growth factor I (IGF-1) and its splice variants as well as IGF-1 receptor, Akt1, mTOR, FOXO1, FOXO3, atrogin, estrogen receptors and androgen receptor in muscle samples. Serum concentrations of IGF-1, E(2) and testosterone were measured. C2C12 myotubes were fed with E₂ or NETA followed by analyzing the expression of essentially the same gene transcripts as in human samples by qPCR and phosphorylation of Akt and mTOR by Western blotting.Results The gene expression of IGF-1 and its splice variant, IGF-1Ec (also known as the mechano growth factor or MGF), mTOR, FOXO3, and AR was up-regulated among the HRT users compared to the CO (P<0.05), while Akt1 was down-regulated (P<0.05). The change in the level of IGF-1Ec transcript correlated positively with muscle size at post-intervention (r=0.5, P<0.05). In C2C12 myotubes, no statistically significant effects of either E₂ or NETA at the level of gene transcripts studied were identified. The amount of phosphorylated Akt appeared to respond to NETA, albeit the response was not statistically significant. Phosphorylation of mTOR did not respond to either of the treatments.Conclusion Year-long postmenopausal HRT was found to affect the expression of the genes along the IGF-1 signaling cascade reflecting the higher muscle mass compared to the CO women. By using cell culture model we were, however, unable to confirm the possible differential role of E₂ and NETA. It appears that the synchronous presence of both effective agents of the HRT or the presence of yet unidentified microenvironmental factors providing proper paracrine signals naturally existing in the intact muscle tissue is critical for appropriate signaling via sex steroid-IGF-1 axis to occur.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ghir.2010.07.003

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent studies suggest a beneficial role for hormone replacement therapy (HRT), supplementation with estrogen and progesterone, and the induction of pathways by which estrogen can aide in skeletal muscle maintenance and repair.

    “Recent studies suggest a beneficial role for hormone replacement therapy (HRT), supplementation with estrogen and progesterone, and the induction of pathways by which estrogen can aide in skeletal muscle maintenance and repair (71).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pöllänen, E., Ronkainen, P. H. A., Horttanainen, M., Takala, T., Puolakka, J., Suominen, H., Sipilä, S., & Kovanen, V.
Affiliations
  • University of Jyväskylä (FI)
  • Oulu Deaconess Institute (FI)
  • Central Finland Health Care District (FI)
Corresponding author
Kovanen, Vuokko
Venue
Growth Hormone & IGF Research
Publisher
Elsevier BV
Published
2010-10
Volume
20
Issue
5
Pages
372-379
ISSN
1096-6374 (ISSN-L)
OpenAlex
W1975249345
Cited by
54
References
59
Citations by year
2025: 3 · 2024: 2 · 2023: 5 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 8 · 2017: 1 · 2016: 5 · 2015: 4 · 2014: 7 · 2013: 4 · 2012: 1
FWCI
1.43
Type
journal article
Language
en
Open access
Locations
  • Growth Hormone & IGF Research (publishedVersion)
  • PubMed (publishedVersion)
  • Jyväskylä University Digital Archive (University of Jyväskylä) (submittedVersion)
Funders
  • Seventh Framework Programme (GA-223576)
  • Suomen Kulttuurirahasto
  • Opetus- ja Kulttuuriministeriö
  • Academy of Finland
  • Jenny ja Antti Wihurin Rahasto
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
combined hormone replacement therapy, IGF-1 signaling, skeletal muscle, postmenopausal women, estradiol, norethisterone acetate, mechano growth factor, IGF-1 receptor, AKT1, mTOR, FOXO3, androgen receptor, estrogen receptor, muscle mass, C2C12 myotubes
MeSH terms
Forkhead Box Protein O1, Forkhead Box Protein O3, Norethindrone Acetate, Estradiol, Female, Humans, Insulin-Like Growth Factor I, Middle Aged, Muscle Proteins, Norethindrone, Receptors, Androgen, Receptors, Estrogen, Testosterone, Transcription, Genetic, Estrogen Replacement Therapy, Randomized Controlled Trials as Topic, Receptor, IGF Type 1, Muscle, Skeletal, Muscle Fibers, Skeletal, Protein Isoforms, SKP Cullin F-Box Protein Ligases, Proto-Oncogene Proteins c-akt, Forkhead Transcription Factors, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review